Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001901033 | SCV002158786 | pathogenic | Ataxia-telangiectasia syndrome | 2021-08-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr316Ilefs*2) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ATM-related conditions. |
Ce |
RCV002275275 | SCV002563083 | pathogenic | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ATM: PVS1, PM2 |
BRCAlab, |
RCV003155978 | SCV002589092 | pathogenic | Familial cancer of breast | 2022-08-26 | no assertion criteria provided | clinical testing |